- Philippine VP Duterte 'mastermind' of assassination plot: justice department
- India two wickets away from winning first Australia Test
- 39 foreigners flee Myanmar scam centre: Thai police
- As baboons become bolder, Cape Town battles for solutions
- Uruguay's Orsi: from the classroom to the presidency
- UN chief slams landmine threat days after US decision to supply Ukraine
- Sporting hope for life after Amorim in Arsenal Champions League clash
- Head defiant as India sense victory in first Australia Test
- Scholz's party to name him as top candidate for snap polls
- Donkeys offer Gazans lifeline amid war shortages
- Court moves to sentencing in French mass rape trial
- 'Existential challenge': plastic pollution treaty talks begin
- Cavs get 17th win as Celtics edge T-Wolves and Heat burn in OT
- Asian markets begin week on front foot, bitcoin rally stutters
- IOC chief hopeful Sebastian Coe: 'We run risk of losing women's sport'
- K-pop fans take aim at CD, merchandise waste
- Notre Dame inspired Americans' love and help after fire
- Court hearing as parent-killing Menendez brothers bid for freedom
- Closing arguments coming in US-Google antitrust trial on ad tech
- Galaxy hit Minnesota for six, Orlando end Atlanta run
- Left-wing candidate Orsi wins Uruguay presidential election
- High stakes as Bayern host PSG amid European wobbles
- Australia's most decorated Olympian McKeon retires from swimming
- Left-wing candidate Orsi projected to win Uruguay election
- UAE arrests three after Israeli rabbi killed
- Five days after Bruins firing, Montgomery named NHL Blues coach
- Orlando beat Atlanta in MLS playoffs to set up Red Bulls clash
- American McNealy takes first PGA title with closing birdie
- Chiefs edge Panthers, Lions rip Colts as Dallas stuns Washington
- Uruguayans vote in tight race for president
- Thailand's Jeeno wins LPGA Tour Championship
- 'Crucial week': make-or-break plastic pollution treaty talks begin
- Israel, Hezbollah in heavy exchanges of fire despite EU ceasefire call
- Amorim predicts Man Utd pain as he faces up to huge task
- Petrol industry embraces plastics while navigating energy shift
- Italy Davis Cup winner Sinner 'heartbroken' over doping accusations
- Romania PM fends off far-right challenge in presidential first round
- Japan coach Jones abused by 'some clown' on Twickenham return
- Springbok Du Toit named World Player of the Year for second time
- Iran says will hold nuclear talks with France, Germany, UK on Friday
- Mbappe on target as Real Madrid cruise to Leganes win
- Israel records 250 launches from Lebanon as Hezbollah targets Tel Aviv, south
- Australia coach Schmidt still positive about Lions after Scotland loss
- Man Utd 'confused' and 'afraid' as Ipswich hold Amorim to debut draw
- Sinner completes year to remember as Italy retain Davis Cup
- Climate finance's 'new era' shows new political realities
- Lukaku keeps Napoli top of Serie A with Roma winner
- Man Utd held by Ipswich in Amorim's first match in charge
- 'Gladiator II', 'Wicked' battle for N. American box office honors
- England thrash Japan 59-14 to snap five-match losing streak
Nobel winner's ingenious chemistry could lead to cancer breakthroughs
"All kinds of crazy things" is how Carolyn Bertozzi, a 2022 Nobel laureate, describes her life's work. Actually performing "chemistry in cells and in people."
When she started her research in 1997, the Stanford professor was aiming only to observe the evolution of certain molecules on the surface of cancer cells.
Today, thanks to her discoveries, at least two companies -- including one she co-founded -- are developing innovative cancer treatments.
The multitude of applications made possible by her findings are impressive: delivering treatments with extreme precision, understanding better how drugs act inside the body, visualizing certain bacteria, to name a few.
"I can't even really enumerate them. The vast majority of those applications I would never have foreseen," she told AFP in an interview.
The Nobel Prize committee recognized Bertozzi's pioneering advances on Wednesday, making her only the eighth woman to win the chemistry prize, at just 55 years old.
- Lego pieces -
Her journey began when she found she had a passion for organic chemistry, while taking pre-medicine courses at Harvard.
The subject is notoriously -- many say fiendishly -- difficult, but she credits an "amazing professor," the late David Evans, for bringing it to life -- and changing the course of her life.
"I said, forget the med school thing. I'm going to be a chemist," said Bertozzi, whose sister is a professor of applied mathematics, and father a retired professor of physics.
After completing her post-doctorate and joining the faculty at UC Berkeley, she wanted to take a closer look at glycans: complex carbohydrates, or sugars, located on the surface of cells, which "go through structural changes" when they become cancerous.
At the time, "there was no tool to image sugars, like in a microscope, for example," she said.
She had an idea that would require two chemical substances that fit together perfectly, like pieces of lego.
The first lego is fed to cells via a sugar. The cell metabolizes it and places it on the tip of the glycan. The second piece of lego, a fluorescent molecule, is injected into the body.
The two lego pieces click together, and voila: hidden glycans reveal themselves under a microscope.
This technique is inspired by "click chemistry" developed independently by Denmark's Morten Meldal and American Barry Sharpless -- Bertozzi's co-winners. But their discoveries relied on using copper as a catalyst, which is toxic to the body.
One of Bertozzi's great leaps was achieving the same type of ultra-efficient reaction without copper.
The other tour de force: making it all happen without wreaking havoc with other processes in the body.
"The beauty of it is that you can take the two Legos and click them together, even if they're surrounded by millions of other very similar plastic toys," she explained.
She coined the term "bioorthogonal chemistry," meaning a reaction that doesn't interfere with other biochemical processes. Perfecting the technique took 10 years.
- 'Cycle of science' -
Researchers are now leveraging these breakthroughs to develop cancer treatments.
Glycans on cancer cells "are able to hide the cancer cell from the immune system -- and so your body can't fight it, it can't see it," she explains.
Using bioorthogonal chemistry, "we made a new type of medicine, which basically acts like a lawnmower," says Bertozzi.
The first lego attaches to the cancer cell's surface, and the second, which clips onto it, is equipped with an enzyme that "mows off the sugars as if they're just grass, it cuts the grass and the sugars fall off," she says with a smile.
The drug is currently being tested in the early stages of a clinical trial.
Another company is seeking to use bioorthogonal chemistry to better target cancer treatment. The first lego piece is injected into a tumor, then a second, which carries the drug, attaches itself and acts only on its target.
"So that allows the oncologist to treat the tumor and kill the tumor without exposing the person's entire body to a toxic chemical," she says.
"What the future holds is hopefully an impact in human health," says Bertozzi. "But the people who decide that more so than myself, are the students and postdocs that join my lab."
Hundreds of them, current and former, filled her email box with messages of congratulations this morning.
"That really is the cycle of science -- it's being mentored and then mentoring" she adds. And "mentoring students gives you an opportunity to amplify the impact of your science."
P.Cavaco--PC